Claritev (NYSE:CTEV – Get Free Report) and OneMedNet (NASDAQ:ONMD – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.
Valuation and Earnings
This table compares Claritev and OneMedNet”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Claritev | $965.41 million | 0.60 | -$284.28 million | ($17.01) | -2.00 |
| OneMedNet | $1.36 million | 25.90 | -$2.80 million | ($0.16) | -3.71 |
Profitability
This table compares Claritev and OneMedNet’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Claritev | -28.46% | N/A | -5.76% |
| OneMedNet | -584.20% | N/A | -521.20% |
Volatility and Risk
Claritev has a beta of 0.74, suggesting that its stock price is 26% less volatile than the S&P 500. Comparatively, OneMedNet has a beta of 1.14, suggesting that its stock price is 14% more volatile than the S&P 500.
Institutional and Insider Ownership
87.2% of Claritev shares are held by institutional investors. Comparatively, 0.9% of OneMedNet shares are held by institutional investors. 7.4% of Claritev shares are held by company insiders. Comparatively, 46.2% of OneMedNet shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of current recommendations and price targets for Claritev and OneMedNet, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Claritev | 1 | 2 | 6 | 0 | 2.56 |
| OneMedNet | 1 | 0 | 0 | 0 | 1.00 |
Claritev currently has a consensus target price of $44.83, indicating a potential upside of 31.98%. Given Claritev’s stronger consensus rating and higher probable upside, equities analysts clearly believe Claritev is more favorable than OneMedNet.
Summary
Claritev beats OneMedNet on 8 of the 13 factors compared between the two stocks.
About Claritev
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.
About OneMedNet
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
Receive News & Ratings for Claritev Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Claritev and related companies with MarketBeat.com's FREE daily email newsletter.
